Sanlam Ltd (SLM)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 8,575.00 |
|---|---|
| 52-week range | 7,643.00 – 10,847.00 |
| Return, 1 month / 3 months | +4.5% / −0.8% |
| Return, 1 year / 3 years | −2.6% / +55.4% |
| Trend | Below its 200-day average |
| RSI (14) | 63 |
| Volatility (1 year) | 24.3% |
| Worst drawdown (1 year) | -23.8% |
| Average daily value traded | 37,286.24M ZAC |
| Dividend yield | 5.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sanlam is a financial services group based in South Africa. It offers life insurance, general insurance, investment management and wealth management to individuals, families and businesses. The company serves customers through a network of advisers, brokers and partners, and it operates in several African countries as well as other international markets. Its business spans personal and commercial insurance, retirement and savings products, and asset management for institutional and retail clients.
On this site Sanlam Ltd appears as a stock on the Johannesburg Exchange (South Africa), code SLM, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sanlam Ltd (SLM) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 8,575.00 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 94 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.6% and over the last three months it fell 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.7% | ||
| From 52-week high | -19.8% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.8% | ||
| 6-month return | -1.4% | ||
| 12-month return, skipping the last month | -6.8% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.8% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 37,286.24M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | +4.5% |
| 3 months | −0.8% |
| 6 months | −1.4% |
| 1 year | −2.6% |
| 3 years | +55.4% |
| 5 years | +85.3% |
Signals
| 50-day / 200-day average | 8,340.62 / 8,809.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 184.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Apr 2026 | ZAC 485.0000 |
| 2 Apr 2025 | ZAC 445.0000 |
| 3 Apr 2024 | ZAC 400.0000 |
| 4 Apr 2023 | ZAC 360.0000 |
| 6 Apr 2022 | ZAC 334.0000 |
| 7 Apr 2021 | ZAC 300.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.